Veritas In Silico (TSE:130A) ROE % Adjusted to Book Value : -0.13% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico ROE % Adjusted to Book Value?

Veritas In Silico's ROE % for the quarter that ended in Jun. 2024 was -0.40%. Veritas In Silico's PB Ratio for the quarter that ended in Jun. 2024 was 3.02. Veritas In Silico's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -0.13%.

Veritas In Silico ROE % Adjusted to Book Value Historical Data

The historical data trend for Veritas In Silico's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico ROE % Adjusted to Book Value Chart

Veritas In Silico Annual Data

Trend

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Veritas In Silico Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Mar24	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-	-3.22	-0.13

Competitive Comparison of Veritas In Silico's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Veritas In Silico's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veritas In Silico's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Veritas In Silico ROE % Adjusted to Book Value Calculation

Veritas In Silico's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.12%	/	N/A
	=	N/A

Veritas In Silico's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-0.40%	/	3.02
	=	-0.13%

Veritas In Silico ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031

Website

https://www.veritasinsilico.com

Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines